No headlines found.
No press releases found.
No news found.
S&P 500 Buy-Write Income's (BXMX) investment objective is to provide a high level of current income and gains. The Fund invests its managed assets in a diversified equity portfolio that seeks to substantially replicate price movements of the S&P 500® Index. The Fund also uses an index option strategy of writing (selling) index call options in seeking to moderate the volatility of returns relative to an all equity portfolio.
Nuveen S&P 500 Buy-Write Income Common Shares Of Beneficial Interest trades on the NYSE stock market under the symbol BXMX.
As of January 13, 2026, BXMX stock price was flat at $14.79 with 162,509 million shares trading.
BXMX has a beta of 0.75, meaning it tends to be less sensitive to market movements. BXMX has a correlation of 0.87 to the broad based SPY ETF.
BXMX has a market cap of $1.54 billion. This is considered a Small Cap stock.
In the last 3 years, BXMX traded as high as $14.84 and as low as $11.25.
BXMX has underperformed the market in the last year with a return of +16.4%, while the SPY ETF gained +20.8%. In the last 3 month period, BXMX fell short of the market, returning +6.1%, while SPY returned +6.5%. However, in the most recent 2 weeks BXMX has outperformed the stock market by returning +2.5%, while SPY returned +0.9%.
BXMX support price is $14.68 and resistance is $14.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BXMX shares will trade within this expected range on the day.
